Array Biopharma Inc.

Array Biopharma Inc. company information, Employees & Contact Information

Array BioPharma Inc. (NASDAQ: ARRY) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics). We have locations in Boulder, CO; Cambridge, MA; and Morrisville, NC.

Company Details

Employees
111
Founded
-
Address
3200 Walnut Street, Boulder,co 80301,united States
Phone
303.381.6600
Email
in****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Boulder, CO
Looking for a particular Array Biopharma Inc. employee's phone or email?

Array Biopharma Inc. Questions

News

Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer - PR Newswire

Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer PR Newswire

Array BioPharma Announces FDA Approval of BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) - MultiVu

Array BioPharma Announces FDA Approval of BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) MultiVu

Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors - PR Newswire

Array BioPharma Names Carrie S. Cox Chairman of its Board of Directors PR Newswire

Array BioPharma Inc., a Subsidiary of Pfizer Inc., Announces Effective Date of Make-Whole Fundamental Change and Fundamental Change Company Notice Relating to its 2.625% Convertible Senior Notes due 2024 - PR Newswire

Array BioPharma Inc., a Subsidiary of Pfizer Inc., Announces Effective Date of Make-Whole Fundamental Change and Fundamental Change Company Notice Relating to its 2.625% Convertible Senior Notes due 2024 PR Newswire

Shalini Sharp Joins Array BioPharma Board of Directors - PR Newswire

Shalini Sharp Joins Array BioPharma Board of Directors PR Newswire

Array BioPharma Announces Strategic Collaboration with Pfizer - PR Newswire

Array BioPharma Announces Strategic Collaboration with Pfizer PR Newswire

John A. Orwin Joins Array BioPharma Board Of Directors - PR Newswire

John A. Orwin Joins Array BioPharma Board Of Directors PR Newswire

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial - PR Newswire

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma in Phase 3 COLUMBUS Trial PR Newswire

Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib - PR Newswire

Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib PR Newswire

Top Array Biopharma Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant